We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jul 2019 11:34

RNS Number : 7376G
Cathay International Holdings Ld
25 July 2019
 

 25 July 2019

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

Cathay International Holdings Limited

("Cathay", the "Company" or the "Group")

Trading update

Hong Kong, 25 July 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"), provides a trading update for the six months ended 30 June 2019.

The Company expects a lower Group sales and profits in the first half 2019 than the same period last year.

As Lansen announced today in Hong Kong, Lansen expects to have noticeable decrease in its net profits for H1 2019 as compared with the net profit for H1 2018 due to the following reasons:

1. As stated in our 2018 annual report, Lansen has implemented a number of new strategic initiatives in its pharmaceutical business, in response to the challenging regulatory environment in China, by developing its own products such as Pafulin, Sicorten Plus, and certain featured pharmaceuticals; and reducing reliance on agency products. As a result, in the first half of the current financial year, Lansen's sales are below the same period last year.

2. A number of provisions and write-offs have been made against old and slow moving inventory.

3. As at 21 June 2019, Lansen decided not to exercise the put option (the "Put Option") to require Natural Dailyhealth to buy back its holding of 30% equity interest in Natural Dailyhealth. As a result, it has written off the related put option value.

Despite the short term impact on Lansen's results from the new strategic initiatives, Lansen sees improvement in its pharmaceutical segment and expects this segment's profit to be higher than that in same period last year, and looks forward to continuing improvement in the second half.

At Haizi, trading has been adversely impacted by a decrease in the market price for inositol and its results are expected to be below 2018.

Natural Dailyhealth and Botai are both trading broadly in line with expectations.

Our hotel remains profitable, although occupancy and average room rates are below last year and profits will be lower for the first half.

 

The Company's results for six months ended 30 June 2019 will be released in late August.

 

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

 

Tel: +852 2828 9289

Consilium Strategic Communications

Mary-Jane Elliott / Matthew Neal / Lindsey Neville

 

 

Tel: +44 (0) 203 709 5702

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKPDNKBKDDOB
Date   Source Headline
1st Apr 20118:59 amRNSGrant of Share Options
24th Mar 20119:02 amRNSAnnual Report and Accounts
18th Mar 20119:09 amRNSGrant of share options
16th Mar 20117:00 amRNSAnnual Results for the Year Ended 31 December 2010
10th Mar 20119:55 amRNSNotice of Results
9th Mar 20117:00 amRNSAppointment of Adviser
29th Nov 20107:30 amRNSZhejiang Starry Pharmaceutical Co., Ltd.
19th Nov 20107:27 amRNSInterim Management Statement
16th Nov 20107:00 amRNSZhejiang Starry Pharmaceutical Co., Ltd.
26th Aug 20105:04 pmRNSINTERIM RESULTS 2010
4th Jun 20107:00 amRNSResults of AGM and change of Director's role
1st Jun 20107:06 amRNSLansen Pharmaceutical Holdings - Update
19th May 20103:32 pmRNSInterim Management Statement
12th May 201010:37 amRNSAnnual Information Update
6th May 20107:32 amRNSLansen Pharmaceutical Holdings Company Limited
27th Apr 20104:25 pmRNSLansen Pharmaceutical Holdings Company Limited
27th Apr 20104:22 pmRNSPRELIMINARY RESULTS
19th Apr 20101:41 pmRNSResult of Special General Meeting
16th Apr 201012:38 pmRNSSpecial General Meeting on 19 April 2010
6th Apr 20105:18 pmRNSPublication of Circular
1st Apr 20101:09 pmRNSLansen Pharmaceutical Holdings Company
23rd Mar 20109:00 amRNSAdditional Listing
26th Feb 20109:07 amRNSAdditional Listing
12th Feb 20106:06 pmRNSUpdate on further investment in Xian Haotian Group
26th Jan 20105:18 pmRNSAnnual Information Update
21st Jan 20105:56 pmRNSAppointment of Directors and Issue of Equity
7th Dec 20099:11 amRNSTotal Voting Rights and Share Capital
4th Dec 200911:16 amRNSResult of SGM
4th Dec 20097:06 amRNSResult of Placing Open Offer
19th Nov 200911:03 amRNSInterim Management Statement
18th Nov 20095:24 pmRNSPublication of Prospectus
18th Nov 20097:00 amRNSPlacing and Open Offer
26th Aug 20092:00 pmRNSInterim Results 2009
22nd Jul 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20094:35 pmRNSPrice Monitoring Extension
26th May 200911:08 amRNSHolding(s) in Company
1st May 20099:30 amRNSDirectorate Change
1st May 20099:28 amRNSResult of AGM
1st May 20097:00 amRNSDIRECTORATE CHANGE
14th Apr 20091:45 pmRNSInterim Management Statement
6th Apr 20095:30 pmRNSPRELIMINARY RESULTS
23rd Jan 200912:27 pmRNSAnnual Information Update
19th Nov 200811:04 amRNSInterim Management Statement
12th Sep 20082:09 pmRNSFurther Update on Xian Haotian
29th Aug 20084:00 pmRNSInterim Results
30th May 20083:18 pmRNSResult of AGM and SGM
19th May 20087:30 amRNSInterim Management Statement
29th Apr 20082:47 pmRNSFinal Results
29th Apr 20088:39 amRNSXian Haotian Circular
28th Apr 20082:09 pmRNSCirc re Xian Haotian

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.